New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

Many Huntington’s researchers who spoke to STAT now believe it represents perhaps the best chance of finally producing a therapy that could delay if not prevent the worst ravages of the disease.

MONDAY, Nov. 4, 2024 (HealthDay News) -- Huntington's disease is a devastating, fatal neurological illness with little means of treatment, but a new study in mice offers a glimmer of hope.

Huntington’s disease specifically destroys the medium spiny neurons, the loss of which causes involuntary muscle movements, impaired mental health, and cognitive decline.

Medically reviewed by Smita Patel, DO Huntington’s disease is a neurological (brain) condition that causes involuntary movement, changes to emotions, behavior, and thinking. Huntington’s is a genetic ...

Huntington's disease leads to degeneration of brain structures called the basal ganglia, which are responsible for control of movement and also play roles in other behaviors, as well as emotions.

More than 600 people will take part in study to test a promising treatment for Huntington's disease, a fatal inherited condition. The experimental drug interferes with defective genetic machinery.

One in 10,000 Americans, or around 30,000 people, have the disease, according to the Huntington’s Disease Society of America. It affects men and women equally across races.

Huntington's disease is an inherited disorder that damages nerve cells and causes parts of the brain to deteriorate, leading to uncontrolled movements and behavioral and cognitive problems.